Yichang HEC ChangJiang Pharmaceutical Co Ltd Ordinary Shares - Class H 01558
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HK$9.10
- Day Range
- HK$8.96–9.33
- 52-Week Range
- HK$6.14–13.30
- Bid/Ask
- HK$9.32 / HK$9.33
- Market Cap
- HK$8.21 Bil
- Volume/Avg
- 2.5 Mil / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 3.56
- Price/Sales
- 1.36
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product, Its products include Kewei, Ertongshu, Xinhaining, Oumeining and Xining.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 4,891
- Website
- http://www.hec-changjiang.com
Comparables
Valuation
|
Metric
|
01558
|
002038
|
688091
|
|---|---|---|---|
Price/Earnings (Normalized) | 3.56 | 48.20 | 77.26 |
Price/Book Value | 0.88 | 1.40 | 4.99 |
Price/Sales | 1.36 | 9.56 | 28.73 |
Price/Cash Flow | 22.21 | 26.14 | 112.55 |
Price/Earnings
01558
002038
688091
Financial Strength
|
Metric
|
01558
|
002038
|
688091
|
|---|---|---|---|
Quick Ratio | 1.38 | 7.46 | 12.24 |
Current Ratio | 2.15 | 13.53 | 12.80 |
Interest Coverage | 12.06 | — | 108.94 |
Quick Ratio
01558
002038
688091
Profitability
|
Metric
|
01558
|
002038
|
688091
|
|---|---|---|---|
Return on Assets (Normalized) | 14.89% | 2.60% | 6.90% |
Return on Equity (Normalized) | 24.50% | 2.77% | 7.29% |
Return on Invested Capital (Normalized) | 17.97% | 2.57% | 5.74% |
Return on Assets
01558
002038
688091
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Flgfxvsj | Dytn | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Hgrdztvmf | Bdtcf | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Xmkgcrjz | Hrgp | $45.9 Bil | |||
| Viatris Inc
VTRS
| Wfmvvppyj | Dxx | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fnmjmzks | Dfkh | $13.2 Bil | |||
| Catalent Inc
CTLT
| Zklsmhjr | Xfqmq | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Hshvvgfnr | Pcnslhx | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Jrtnpljg | Wkxmz | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Qptfcfzr | Brzd | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Wnhmpdmg | Vxvv | $2.2 Bil |
United States